Prothena Corporation (PRTA)
NASDAQ: PRTA
· Real-Time Price · USD
5.06
0.18 (3.69%)
At close: Jun 05, 2025, 3:59 PM
4.98
-1.58%
After-hours: Jun 05, 2025, 07:19 PM EDT
3.69% (1D)
| Bid | 4.4 |
| Market Cap | 272.36M |
| Revenue (ttm) | 137.94M |
| Net Income (ttm) | -110.27M |
| EPS (ttm) | -2.05 |
| PE Ratio (ttm) | -2.47 |
| Forward PE | -1.59 |
| Analyst | Buy |
| Ask | 5.39 |
| Volume | 1,356,042 |
| Avg. Volume (20D) | 1,313,453 |
| Open | 4.82 |
| Previous Close | 4.88 |
| Day's Range | 4.77 - 5.18 |
| 52-Week Range | 4.32 - 25.42 |
| Beta | -0.08 |
About PRTA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PRTA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PRTA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
-30.4%
Prothena shares are trading lower after HC Wainwri...
Unlock content with
Pro Subscription
5 months ago
+33.97%
Prothena shares are trading higher after the Phase IIb Prasinezumab study showed potential in early Parkinson's disease.
